skip to navigation skip to content

 

Nano Magazine: UK company tackling MS wins global medicine award

LIFNanoRX, a venture that targets multiple sclerosis (MS), is named Most Promising Nanomedicine Project at the annual BIO-Europe conference. LIFNano is currently on the Accelerate Cambridge programme run by the Cambridge Judge Entrepreneurship Centre, and previously was supported by the Cambridge Social Ventures programme at the Cambridge Centre for Social Innovation at Cambridge Judge.

Read the full article [nano-magazine.com]